A detailed history of Gabelli Funds LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 127,500 shares of TMCI stock, worth $887,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
127,500
Previous 127,500 -0.0%
Holding current value
$887,400
Previous $847,000 12.75%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.17 - $12.62 $66,132 - $200,140
-15,859 Reduced 11.06%
127,500 $847,000
Q4 2023

Feb 13, 2024

BUY
$6.03 - $12.88 $12,705 - $27,138
2,107 Added 1.49%
143,359 $1.83 Million
Q3 2023

Nov 08, 2023

BUY
$12.16 - $24.87 $789,901 - $1.62 Million
64,959 Added 85.14%
141,252 $1.85 Million
Q1 2023

May 12, 2023

BUY
$20.23 - $26.22 $1.54 Million - $2 Million
76,293 New
76,293 $1.92 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $386M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.